Kaiser Permanente to return $500M in coronavirus aid

Kaiser Permanente is among a handful of major healthcare organizations that have promised to refund the government millions in aid meant to help health systems and hospitals deal with the COVID-19 pandemic. Specifically, Kaiser CEO Greg Adams says the California-based nonprofit heath system will return more than $500 million, but also keep $11.8 million designated for Maui Health System, a subsidiary of Kaiser Foundation Hospital, according to San Francisco Business Times.

Kaiser follows in the footsteps of CVS Health, which returned $43 million in federal aid, as well as Encompass, Cigna and DaVita, which also returned millions. The aid was doled out quickly from a $30 billion fund destined for healthcare companies in the CARES Act. The companies receiving funds were based on recent Medicare billings, but the Trump administration eventually issued guidance for companies to accept or return the money.

Adams noted the $500 million return while speaking about numerous topics in an interview, including the recent social injustice protests and COVID-19. While Kaiser expects its financial plan and budget to be “off” for the year, “we will do fine,” Adams told the publication. Kaiser made the decision to scrap its planned $900 million headquarters in March.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

California-based Acutus Medical has said its ongoing agreement to manufacture and distribute left-heart access devices for Medtronic is the company's only source of revenue. 

The scam took place over a period of seven years, resulting in Medicare being billed for more than $70 million in fraudulent claims for unnecessary scans. 

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.